{"id":"https://openalex.org/W2252355792","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.e22124","title":"Relationship of systemic immune dysregulation in advanced tumors to vascular growth factor overproduction","display_name":"Relationship of systemic immune dysregulation in advanced tumors to vascular growth factor overproduction","publication_year":2009,"publication_date":"2009-05-20","ids":{"openalex":"https://openalex.org/W2252355792","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.e22124","mag":"2252355792"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2009.27.15_suppl.e22124","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.e22124","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2009.27.15_suppl.e22124","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000164383","display_name":"Matthew Stephen Block","orcid":"https://orcid.org/0000-0001-5692-4219","observed_orcids":["https://orcid.org/0000-0001-5692-4219"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. S. Block","raw_affiliation_strings":["Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082719040","display_name":"Svetomir N. Markovic","orcid":"https://orcid.org/0000-0002-9238-4325","observed_orcids":["https://orcid.org/0000-0002-9238-4325"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. N. Markovic","raw_affiliation_strings":["Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1330342723"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"27","issue":"15_suppl","first_page":"e22124","last_page":"e22124"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.8901000022888184,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.8901000022888184,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.045099999755620956,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.03530000150203705,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.7289999723434448},{"id":"https://openalex.org/keywords/placental-growth-factor","display_name":"placental growth factor","score":1.0},{"id":"https://openalex.org/keywords/tumor-immunosuppression","display_name":"tumor immunosuppression","score":0.7369999885559082},{"id":"https://openalex.org/keywords/il-10","display_name":"IL-10","score":0.8259999752044678},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.847000002861023},{"id":"https://openalex.org/keywords/splenocytes","display_name":"splenocytes","score":0.8429999947547913},{"id":"https://openalex.org/keywords/t-cell-receptor-activation","display_name":"T cell receptor stimulation","score":0.8169999718666077},{"id":"https://openalex.org/keywords/advanced-cancer","display_name":"advanced cancer","score":0.593999981880188},{"id":"https://openalex.org/keywords/breast-tumors","display_name":"breast tumors","score":0.5550000071525574},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.6359999775886536},{"id":"https://openalex.org/keywords/transplantable-tumors","display_name":"transplantable tumors","score":0.503000020980835}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8001646995544434},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.6598607897758484},{"id":"https://openalex.org/C189976730","wikidata":"https://www.wikidata.org/wiki/Q3493700","display_name":"Splenocyte","level":3,"score":0.6232481002807617},{"id":"https://openalex.org/C2780252810","wikidata":"https://www.wikidata.org/wiki/Q1455316","display_name":"Immunosuppression","level":2,"score":0.598013699054718},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.5809692740440369},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.48830318450927734},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.46711835265159607},{"id":"https://openalex.org/C49382859","wikidata":"https://www.wikidata.org/wiki/Q286498","display_name":"Lymphokine","level":3,"score":0.4575871229171753},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4300982654094696},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.367903470993042},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.34751570224761963},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.11048164963722229}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2009.27.15_suppl.e22124","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.e22124","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2009.27.15_suppl.e22124","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2107083699","https://openalex.org/W2955722147","https://openalex.org/W147937016","https://openalex.org/W3083481024","https://openalex.org/W2741099662","https://openalex.org/W2131627025","https://openalex.org/W2057427371","https://openalex.org/W4294032364","https://openalex.org/W2150581120","https://openalex.org/W4402301549"],"abstract_inverted_index":{"e22124":[0],"Background:":[1],"Therapeutic":[2],"anti-cancer":[3],"vaccine":[4,291],"strategies":[5],"have":[6,26,33,42,65,91,233,253],"been":[7],"effective":[8],"in":[9,22,153,214,220,264,280,287],"a":[10],"broad":[11],"range":[12],"of":[13,20,49,69,158,177,217,244,261],"preclinical":[14],"tumor":[15],"models,":[16],"but":[17],"clinical":[18,30],"trials":[19],"vaccines":[21],"metastatic":[23],"cancer":[24],"patients":[25,37],"failed":[27],"to":[28,56,259,300],"show":[29],"benefit.":[31],"We":[32,232,252],"previously":[34],"shown":[35,234,255],"that":[36,93,235,256,272],"with":[38,60,108,166,237,282],"stage":[39,61],"IV":[40,62],"melanoma":[41,63],"systemic":[43,103,249],"immunosuppression":[44,279],"including":[45],"elevated":[46,66,174,242],"plasma":[47,117,175],"levels":[48,68,176,243],"immunosuppressive":[50,182],"cytokines":[51],"and":[52,81,100,116,124,140,168,180,248],"impaired":[53],"DTH":[54],"responses":[55],"recall":[57],"antigens.":[58],"Patients":[59],"also":[64,254],"circulating":[67],"the":[70,135,154,181,215],"vascular":[71,74,94,245,274],"growth":[72,76,83,95,246,275],"factors":[73,96,247,276],"endothelial":[75],"factor":[77,84],"A":[78],"(VEGF":[79],"A)":[80],"placental":[82],"(PlGF).":[85],"Based":[86],"on":[87],"these":[88,269],"observations,":[89],"we":[90],"hypothesized":[92],"such":[97],"as":[98],"VEGF":[99,218,257],"PlGF":[101],"mediate":[102,278],"immunosuppression.":[104],"Methods:":[105],"FVB":[106],"mice":[107,131,150,172,192,236],"established":[109],"ANV6":[110],"transplantable":[111],"breast":[112],"tumors":[113,239],"were":[114,119,132,151],"bled,":[115],"samples":[118],"assayed":[120],"for":[121],"VEGF,":[122,178],"PlGF,":[123,179],"interleukin":[125],"(IL)-10.":[126],"Splenocytes":[127,147],"taken":[128],"from":[129,148,190,202],"tumor-bearing":[130,171,191],"stimulated":[133,152,213],"via":[134],"T":[136],"cell":[137],"receptor":[138],"(TCR),":[139],"interferon":[141],"gamma":[142],"(IFN)":[143],"production":[144,161],"was":[145,162],"measured.":[146,163],"normal":[149,206,265],"presence":[155,216],"or":[156],"absence":[157,222],"VEGF;":[159],"IFN":[160,195,211],"Results:":[164],"Compared":[165],"age-":[167],"sex-matched":[169],"controls,":[170],"had":[173],"cytokine":[183],"IL-10":[184],"(see":[185],"table":[186],").":[187],"Furthermore,":[188],"splenocytes":[189,201,208],"produced":[193,209],"less":[194,210],"upon":[196],"TCR":[197],"stimulation":[198],"than":[199,219],"did":[200],"control":[203],"mice.":[204],"Finally,":[205],"mouse":[207],"when":[212],"its":[221],"(70.2":[223],"\u00b1":[224,228],"37.2":[225],"vs.":[226],"260.0":[227],"130.9":[229],"pg/ml).":[230],"Conclusions:":[231],"advanced":[238,283],"exhibit":[240],"both":[241],"immune":[250,262],"inhibition.":[251],"leads":[258],"impairment":[260],"function":[263],"splenocytes.":[266],"Taken":[267],"together,":[268],"results":[270],"suggest":[271],"excess":[273],"may":[277,286],"animals":[281],"tumors,":[284],"which":[285],"turn":[288],"impair":[289],"anti-tumor":[290],"efficacy.":[292],"[Table:":[293],"see":[294],"text]":[295],"No":[296],"significant":[297],"financial":[298],"relationships":[299],"disclose.":[301]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}